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Abstract
Background: The ubiquitin-proteasome system is responsible for homeostatic degradation of intact
protein substrates as well as the elimination of damaged or misfolded proteins that might otherwise
aggregate. During ageing there is a decline in proteasome activity and an increase in aggregated proteins.
Many neurodegenerative diseases are characterised by the presence of distinctive ubiquitin-positive
inclusion bodies in affected regions of the brain. These inclusions consist of insoluble, unfolded,
ubiquitinated polypeptides that fail to be targeted and degraded by the proteasome. We are using a
systems biology approach to try and determine the primary event in the decline in proteolytic capacity
with age and whether there is in fact a vicious cycle of inhibition, with accumulating aggregates further
inhibiting proteolysis, prompting accumulation of aggregates and so on. A stochastic model of the
ubiquitin-proteasome system has been developed using the Systems Biology Mark-up Language (SBML).
Simulations are carried out on the BASIS (Biology of Ageing e-Science Integration and Simulation) system
and the model output is compared to experimental data wherein levels of ubiquitin and ubiquitinated
substrates are monitored in cultured cells under various conditions. The model can be used to predict the
effects of different experimental procedures such as inhibition of the proteasome or shutting down the
enzyme cascade responsible for ubiquitin conjugation.
Results: The model output shows good agreement with experimental data under a number of different
conditions. However, our model predicts that monomeric ubiquitin pools are always depleted under
conditions of proteasome inhibition, whereas experimental data show that monomeric pools were
depleted in IMR-90 cells but not in ts20 cells, suggesting that cell lines vary in their ability to replenish
ubiquitin pools and there is the need to incorporate ubiquitin turnover into the model. Sensitivity analysis
of the model revealed which parameters have an important effect on protein turnover and aggregation
kinetics.
Conclusion: We have developed a model of the ubiquitin-proteasome system using an iterative approach
of model building and validation against experimental data. Using SBML to encode the model ensures that
it can be easily modified and extended as more data become available. Important aspects to be included in
subsequent models are details of ubiquitin turnover, models of autophagy, the inclusion of a pool of short-
lived proteins and further details of the aggregation process.
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Background
Ageing is due to the gradual accumulation of unrepaired
random molecular faults, which leads to an increased frac-
tion of damaged cells and eventually to the functional
impairment of older tissues and organs [reviewed in [1]].
Cellular components are continuously renewed by the
processes of catabolism and resynthesis as they wear out
or become damaged. However the mechanisms of
renewal are not perfectly efficient and over time there may
be an increase in damaged molecular structures. For
example, there is an accumulation of incompletely
degraded intralysosomal waste material, known as lipo-
fuscin, in postmitotic cells [2]. In 2001, Terman proposed
the "garbage catastrophe theory" of ageing [3] which
states that the process of ageing may derive from imperfect
clearance of oxidatively damaged, relatively indigestible
material, the accumulation of which further hinders cellu-
lar catabolic and anabolic functions. Terman points out
that this theory applies mainly to postmitotic cells and
not to proliferating cells. This is supported by the evidence
that tissues composed of postmitotic cells such as the
heart and brain show the most pronounced age-related
changes [4,5], whereas tissues with constantly proliferat-
ing cell populations such as the intestinal epithelium
show only minor changes with age [6]. A possible reason
for this difference is that during cell growth and division,
most cellular structures are renewed and there is a dilution
of any undigested material.
Terman mainly applied his theory to the lysosomal path-
way of degradation. He suggested that lysosomes gradu-
ally accumulate lipofuscin and that the lipofuscin
granules attract lysosomal enzymes which, however, fail
to degrade the pigment. This leads to a shortage in lyso-
somal enzymes, resulting in a decrease in degradation by
this pathway. However, the major pathway for the rapid
degradation of proteins is the ubiquitin-proteasome path-
way. Proteins need to be degraded either because they are
short-lived e.g. key regulatory proteins or because they
have become damaged and partially unfolded. Partially
unfolded proteins have exposed hydrophobic surfaces
and are liable to form aggregates. Molecular chaperones
bind to the exposed surfaces and an attempt is made to
refold the protein. If refolding is unsuccessful then chap-
erones assist in the removal of these proteins and so pre-
vent their aggregation [7].
Interestingly, proteasomes themselves are degraded by the
lysosomal system and there is evidence for cross-talk
between the two degradation pathways [8,9]. It has been
observed that there is a progressive decline in the overall
proteolytic capacity of the cell with age [10,11] resulting
in an accumulation of oxidized and cross-linked proteins
[12,13]. These observations have been linked to an
increase in free radicals with age [11]. However, there is
also evidence that free radicals do not increase with age
[14,15], suggesting that the observed increase in damaged
proteins may be a result of a decline in removal of damage
rather than an increase in the rate of damage itself. Pro-
teins that have been damaged by free radicals appear
resistant to proteolytic degradation and can act as inhibi-
tors of lysosomal hydrolases and proteasome activity [16].
The small aggregates which precede the formation of
mature amyloid fibres are particularly pathogenic in
many amyloid diseases [17]. Sitte et al[12] found a dra-
matic decline of proteasome activity, but not of proteas-
ome enzyme levels in nondividing human BJ fibroblasts
during hyperoxic ageing. Such a decline is not a cell cul-
ture artefact because it has been observed in many tissues
including cardiac and skeletal muscle, skin, lens and brain
(reviewed in [18]). Sitte et al[12] did not observe a
decrease in lysosomal activity with time in nondividing BJ
fibroblasts. However, both proteasome and lysosomal
activity decreased in proliferating BJ fibroblasts [13].
It has been reported that aggregated protein directly
impairs the function of the ubiquitin-proteasome system
[19,20]. Another set of data indicates that aggregation
occurs when the capacity of the proteasome degradation
pathway is exceeded but no distinction could be drawn
between the possibility of increased substrate expression
or a decline in proteasome activity [21]. Therefore, it is not
clear whether aggregated protein directly impairs proteol-
ysis or whether its presence is a symptom of impaired pro-
teolysis. The issues of cause versus effect require further
investigation particularly in the role of ageing.
Many neurodegenerative diseases are characterised by the
presence of distinctive ubiquitin-positive inclusion bodies
in affected regions of the brain. These inclusions consist of
insoluble, unfolded, ubiquitinated polypeptides that fail
to be targeted and degraded by the proteasome [22]. It has
been suggested that cells possess a protective mechanism
to sequester and isolate toxic misfolded cytoplasmic inter-
mediates by delivering them to ubiquitin-rich structures,
called aggresomes at the microtubule-organising centre
(MTOC) [21]. Nuclear inclusions may serve a similar
function, sequestering aggregation-prone polypeptides
into relatively inert higher-order complexes. It has been
demonstrated that misfolded proteins are less toxic to
cells capable of forming nuclear inclusions [23].
In order to be recognised and degraded by the 26S protea-
some, proteins must first be tagged with chains of four or
more ubiquitin molecules. Ubiquitin is a small protein
found in all eukaryotic organisms. Ubiquitination occurs
as a result of the sequential activity of three classes of
enzymes, E1 (ubiquitin activating enzyme), E2 (ubiquitin
conjugating enzyme), and E3 (ubiquitin protein ligase).
In the first step, ubiquitin is activated through ATP hydrol-BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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ysis mediated by an E1 enzyme. The activated ubiquitin is
then transferred to an E2 (ubiquitin conjugate) enzyme.
There are approximately 50 different E2 proteins in mam-
malian cells [24] that have limited substrate specificities.
E2 bound to ubiquitin then forms a complex with an E3
(ubiquitin ligase) enzyme. There are hundreds of E3 pro-
teins [24] specific for different substrates. Three classes of
E3 proteins have been identified: the HECT (homologous
to E6-AP C-terminus), the RING (really interesting new
gene) finger, and the U-box domain types (see review by
Robinson and Ardley [25]). The following describes the
action of a HECT E3. As well as binding to the E2-ubiqui-
tin complex, E3 binds to the protein which is to be
degraded. The activated ubiquitin is then transferred to
the substrate with the release of E2 and E3. At this stage
the protein is mono-ubiquitinated. Further ubiquitin is
then attached to form a chain by the further action of E1
and E2 enzymes. A ubiquitin chain of at least four ubiqui-
tin molecules has physical affinity for the proteasome and
delivers the substrate for degradation in an ATP-depend-
ent manner [26]. During degradation, the ubiquitin is
released for recycling and the protein is cleaved into short
peptides, which are then reduced to amino-acids by
cytosolic proteases. Note that for simplicity our model
ignores alternative mechanisms of chain assembly (conju-
gation of preassembled chains onto substrates etc., as dis-
cussed in [27], and does not require the activity of E4
enzymes, which for some substrates may promote chain
elongation [28].
A large number of de-ubiquitinating enzymes (DUBs) are
also found within all eukaryotic cells [29]. In addition to
processing the primary pro-protein translation products
of the ubiquitin genes DUBs may edit polyubiquitin
chains on substrates and thereby prolong the half-life of
such substrates by preventing the formation of threshold
length chains required for proteasome binding.
A model of protein turnover and the role of the molecular
chaperone Hsp90 in maintaining protein homeostasis has
previously been developed [30]. This model contains a
pool of proteins in its correctly folded native state (repre-
sented by a species NatP). At any point in time, a native
protein can become misfolded with the rate of this reac-
tion depending on the level of reactive oxygen species
(ROS) within the cell (higher levels of ROS lead to an
increase in the rate of misfolding). The pool of misfolded
proteins is represented by a species MisP. There are three
possible outcomes for a misfolded protein. The first pos-
sibility is that a misfolded protein binds to Hsp90 and
once bound, it can either be refolded and return to the
pool of native protein or it may dissociate from Hsp90
and so remain in its misfolded state. Secondly, a mis-
folded protein may be degraded and so removed. Thirdly,
a misfolded protein may bind to another misfolded pro-
tein to form a small aggregate (or bind to a previously
formed aggregate). The model contains details of the reg-
ulation of Hsp90 through its interaction with Heat Shock
Factor-1 (HSF1). However, no detail is included of either
the degradation pathway or the process of aggregation.
The aim of this paper is to show that the model previously
used to simulate chaperone function can be extended to
model ubiquitin-mediated proteolysis, incorporating
molecular details of this degradation system. We have also
sought to incorporate details of the aggregation process.
One approach would be to take the computer code for the
chaperone model and then extend the code. However, a
better approach is to build a new and separate model that
can be tested individually and then linked with the chap-
erone model. A network diagram of the ubiquitin-protea-
some model is given in Figure 1. Details of how the model
was built are given in the Methods section.
Results
Normal conditions
The model was simulated with the initial values and
parameter values given in Tables 1 and 2 respectively.
Since the model is stochastic, each simulation produces
slightly different results even when starting with the same
set of initial values and parameter values. Figure 2a shows
the random fluctuations for two of the model species
when simulations are repeated 100 times. The model pre-
dicts that the level of native protein remains fairly con-
stant, with a mean value of 499.0 with some small
fluctuations due to stochastic effects and the level of mis-
folded protein remains low with a mean of 5.8 misfolded
proteins at any one time. The mean values were calculated
over a five hour time period from 100 simulations. The
model output for a range of species from a single simula-
tion is shown in Figure 2b. Initially there is a very steep
decline in monomeric ubiquitin corresponding to the
pool of ubiquitin that binds to E1 and E2. The pool of free
ubiquitin further declines as misfolded protein is ubiqui-
tinated. When the system settles down after about two
hours, the pool of ubiquitin conjugates is larger than the
pool of monomeric ubiquitin which agrees with experi-
mental data (Fig 2b(ii)). The fluctuations in the ubiquitin
pools are mainly due to the fluctuations in the amount of
ubiquitin bound to misfolded proteins including those
bound at the proteasome due to the opposing reactions of
ubiquitination and de-ubiquitination. Some of the varia-
tion is also caused by fluctuations in the amount of E1
bound to ubiquitin (see Fig 2b(iii)). We kept track of the
number of degradation reactions and the length of ubiq-
uitin chain at the time of degradation. We found that the
number of degradation reactions increases with the length
of chain (Fig 2b(iv)). Since the degradation rate does not
depend on chain length, then the reason that misfolded
proteins with longer polyubiquitin chains are more likelyBMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Network diagram of the ubiquitin-proteasome model Figure 1
Network diagram of the ubiquitin-proteasome model. (a) Reactions leading to the first ubiquitination step; (b) reac-
tions of chain lengthening and shortening (only shown for chains up to length four); (c) binding of substrate with polyubiquitin 
chains (of length four or more) to proteasome and chain shortening of bound substrates by DUBs which leads to release from 
proteasome when chain is less than four; (d) degradation of substrates by proteasome in ATP-dependent manner releasing 
ubiquitin for recycling; (e) formation of aggregated proteins, sequestering of aggregates and proteasome inhibition by aggre-
gates.
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to be degraded is that they spend more time physically
associated with the proteasome. Under normal condi-
tions, there is no formation of aggregates and so no inhi-
bition of the proteasome (Fig 2b(v),(vi)). The levels of
available unbound proteasomes fluctuate between 75 and
100, as a result of varying levels in bound polyubiquiti-
nated protein.
We carried out a sensitivity analysis to see how changing
each of the model parameters affects the simulation out-
put. The only parameters which have a significant effect
on the results when increased or decreased by an order of
magnitude were k1, k2, k67, k68, and k69. Varying the
parameter for protein synthesis, k1, affects the levels of
native protein but only an increase in k1 has any affect on
any of the other species. Increasing protein synthesis leads
to a depletion in monomeric ubiquitin pools due to the
increase pool of protein requiring degradation. An
increase in the parameter for misfolding, k2, leads to an
increase in misfolded protein, a decrease in native protein,
all the ubiquitin ending up in conjugates and an increase
in degradation. Conversely, a decrease in k2, leads to
higher levels of native protein, more monomeric ubiqui-
tin, less ubiquitin conjugates and less degradation.
Increasing the parameter for binding of polyubiquitinated
misfolded protein to the proteasome, k67, has no effect
on the model output, but a decrease in k67 leads to a
depletion in monomeric ubiquitin pools, an increase in
unbound polyubiquitinated misfolded protein and less
degradation. Increasing the parameter for the chain short-
ening of polyubiquitinated misfolded protein, k68, has
the same effect as decreasing k67. However, decreasing
k68 has little effect on model output except that nearly all
the degradation reactions are via the substrates with the
longest ubiquitin chain. Increasing the parameter for pro-
teasome activity, k69, leads to more degradation and less
ubiquitin conjugates, whereas decreasing k69 has the
opposite effect and also results in depletion of mono-
meric ubiquitin due to less recycling of ubiquitin.
Proteasome inhibition
We carried out an in silico experiment of inhibiting the
proteasome by setting the parameter k69 = 0. The model
predicts that there is initially a build up of ubiquitinated
protein and that the pool of monomeric ubiquitin is
depleted. The depletion of ubiquitin is followed by a
steady rise in the level of misfolded protein (Fig 3a). Note
that our experimental data invariably show a decline in
monomeric ubiquitin in IMR90 cells but that the results
are more variable in ts20 cells; in some experiments there
is no evidence of depletion in monomeric ubiquitin in the
ts20 cells (Fig 3b) This suggests that there is compensatory
upregulation of ubiquitin in ts20 cells after proteasome
inhibition. Currently our model assumes that the total
Table 1: List of species with database terms and initial conditions
Species description Species Name Database term Initial Amount
Native protein NatP N/A 500
Misfolded protein MisP N/A 0
Ubiquitin Ub IPR000626 500
Ubiquitin activating enzyme E1 IPR000011 100
Ubiquitin conjugating enzyme E2 IPR000608 100
Ubiquitin ligase (HECT) E3 IPR000569 100
De-ubiquitinating enzyme DUB IPR001394 200
Proteasome Proteasome GO:0000502 100
Reactive oxygen species ROS CHEBI:26523 10
Adenosine triphosphate ATP CHEBI:15422 10000
Adenosine diphosphate ADP CHEBI:16761 1000
Adenosine monophosphate AMP CHEBI:22254 1000
Misfolded protein bound by E3 E3_MisP IPR000569 0
E1 bound by Ub E1_Ub IPR000011 0
E2 bound by Ub E2_Ub IPR000608 0
Monoubiquitinated misfolded protein MisP_Ub IPR000626 0
Polyubiquitinated misfolded protein MisP_Ub2, ... MisP_Ub8 IPR000626 0
Polyubiquitinated protein bound to proteasome MisP_Ub4_Proteasome ... 
MisP_Ub8_Proteasome
IPR000626 GO:0000502 0
Aggregated protein AggP N/A 0
Sequestered aggregated protein SeqAggP N/A 0
Aggregated protein bound to proteasome AggP_Proteasome GO:0000502 0
Dummy species to track chain length of substrate at 
degradation
degUb4, ..., degUb8 N/A 0
IPR: InterPro [46]
GO: Gene ontology [47]
CHEBI: Chemical Entities of Biological Interest database [48]B
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Table 2: List of reactions and parameter values for the ubiquitin-proteasome system
Reaction Kinetic rate law Reactants Products Parameter
name
Valuea
Protein synthesis k1 NatP k1 0.01 mol s-1
Misfolding k2<#NatP><#ROS> NatP, ROS MisP, ROS k2 2.0E-6 mol-1 s-1
Refolding k3 <#MisP> MisP NatP k3 4.0E-6 s-1
MisP/E3 binding k61 <#E3><#MisP> E3, MisP E3_MisP k61 1.7E-5 mol-1 s-1
MisPE3 release k61r <#E3_MisP> E3_MisP E3, MisP k61r 2.0E-4 s-1
E1/Ub binding k62 <#E1><#Ub><#ATP>/(5000+<#ATP>) E1, Ub, ATP E1_Ub, AMP k62 2.0E-4 mol-1 s-1
E2/Ub binding k63 <#E2><#E1_Ub> E2, E1_Ub E1, E2_Ub k63 1.0E-3 mol-1 s-1
Monoubiquitination k64 <#E2_Ub><#E3_MisP> E2_Ub, E3_MisP E2, E3, MisP_Ub k64 1.0E-3 mol-1 s-1
Polyubiquitination1 k65 <#E2_Ub><#MisP_Ub> E2_Ub, MisP_Ub MisP_Ub2 k65 1.0E-2 mol-1 s-1
Polyubiquitination2 k65 <#E2_Ub><#MisP_Ub2> E2_Ub, MisP_Ub2 MisP_Ub3 k65 1.0E-2 mol-1 s-1
   
Polyubiquitination7 k65 <#E2_Ub><#MisP_Ub8> E2_Ub, MisP_Ub7 MisP_Ub8 k65 1.0E-2 mol-1 s-1
De-ubiquitination1 k66 <#DUB><#MisP_Ub8> DUB, MisP_Ub8 DUB, MisP_Ub7, Ub k66 1.0E-5 mol-1 s-1
   
De-ubiquitination8 k66 <#DUB><#MisP_Ub> DUB, MisP_Ub DUB, MisP, Ub k66 1.0E-5 mol-1 s-1
Proteasome binding1 k67 <#MisP_Ub4><#Proteasome> MisP_Ub4, Proteasome MisP_Ub4_ Proteasome k67 1.0E-5 mol-1 s-1
   
Proteasome binding5 k67 <#MisP_Ub8><#Proteasome> MisP_Ub8, Proteasome MisP_Ub8_ Proteasome k67 1.0E-5 mol-1 s-1
De-ubiquitinationBoundMisP1 k68 <#DUB><#MisP_Ub4_Proteasome> DUB, MisP_Ub4_Proteasome DUB, MisP_Ub3, Ub, Proteasome k68 1.0E-5 mol-1 s-1
De-ubiquitinationBoundMisP2 k68 <#DUB><#MisP_Ub5_Proteasome> DUB, MisP_Ub5_Proteasome DUB, Ub, MisP_Ub4_Proteasome k68 1.0E-5 mol-1 s-1
   
De-ubiquitinationBoundMisP5 k68 <#DUB><#MisP_Ub8_Proteasome> DUB, MisP_Ub8_Proteasome DUB, Ub, MisP_Ub7_Proteasome k68 1.0E-5 mol-1 s-1
ProteasomeActivity1 k69 <#MisP_Ub4_Proteasome><#ATP>/(5000+<#ATP>) ATP, MisP_Ub4_ Proteasome ADP, Proteasome, 4Ub, k69 1.0E-3 s-1
   
ProteasomeActivity 5 k69 <#MisP_Ub8_Proteasome><#ATP>/(5000+<#ATP>) ATP, MisP_Ub8_ Proteasome ADP, Proteasome, 8Ub, k69 1.0E-3 s-1
amol, number of moleculesBMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Model output under normal conditions Figure 2
Model output under normal conditions. (a) Stochastic variation. Simulations were repeated 100 times and the mean for 
two of the species plotted. The black lines show the mean values, the green and red lines show the upper and lower 95% con-
fidence interval respectively. (i) Native protein (NatP). (ii) Misfolded protein (MisP). (b) Results are shown for a typical simula-
tion, for a 10 hour period. (i) Level of native protein (NatP), misfolded protein (MisP), and misfolded protein bound to E3 
(E3_MisP). (ii) Ubiquitin pools. (iii) Ubiquitin bound to E1 and E2 (E1_Ub and E2_Ub respectively). (iv) Cumulative number of 
degradation reactions for different length of ubiquitin chains bound to substrate. (v) Accumulation of aggregated protein 
(AggP), sequestered aggregated protein (SeqAggP) and aggregated protein bound to proteasomes (AggP_Proteasome). (vi) 
Available pool of proteasomes, number of proteasomes bound by substrates and number of proteasomes bound by aggregated 
proteins.BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Inhibiting proteasome activity Figure 3
Inhibiting proteasome activity. Results are shown for a typical simulation, for a 20 hour period (a) Model output (k69 = 0, 
all other parameters as in Tables 2 and 3). (i) Level of native protein (NatP), misfolded protein (MisP), and misfolded protein 
bound to E3 (E3_MisP). (ii) Ubiquitin pools. (iii) Ubiquitin bound to E1 and E2 (E1_Ub and E2_Ub respectively). (iv) Cumulative 
number of degradation reactions for different length of ubiquitin chains bound to substrate. (v) Accumulation of aggregated 
protein (AggP), sequestered aggregated protein (SeqAggP) and aggregated protein bound to proteasomes (AggP_Proteasome). 
(vi) Available pool of proteasomes, number of proteasomes bound by substrates and number of proteasomes bound by aggre-
gated proteins. (b) Survey of ubiquitin pools in various cell lines. Western blot analysis of cell extracts from U87MG, 
NIH-3T3, IMR90 and ts20 cells with an antibody raised against ubiquitin. The pool of conjugated ubiquitin (vertical line) was 
found to differ between cell lines with the highest levels detected in NIH-3T3 cells. Comparable levels of conjugated ubiquitin 
were detected in IMR90, U87MG and ts20 cells cultured at 34°C. ts20 cells cultured at 42°C for 3 hours had the least detect-
able levels of poly-ubiquitinated conjugates. Whereas a shift from monomeric (arrowhead) to conjugated ubiquitin (vertical 
line) was observed in IMR90 cells treated with proteasome inhibitor for 3 hours, no difference in the pool of monomeric ubiq-
uitin was observed in ts20 cells treated with the inhibitor. The membrane was re-probed with an antibody directed against 
GAPDH which served as a loading control (boxed panel).BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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pool of ubiquitin remains constant but the model can eas-
ily be extended to include detail of ubiquitin turnover
(Proctor, Tsirigotis, & Gray, in preparation). The model
predicts that the level of native protein is not affected, as
protein synthesis continues at the same rate and so
replaces any protein which becomes misfolded (Fig 3a).
Aggregated protein starts to form after five hours and there
is a low level of aggregates bound to proteasomes.
We also varied each of the parameters in turn to see which
parameters affect the kinetics of aggregation. We found
that apart from the parameters actually involved in the
aggregation steps (k71, k72, k73, k74), the only parameters
which affect aggregation are k1, k2, k3 and k61, Either an
increase in protein synthesis (k1) or in the misfolding rate
(k2) leads to an increase in aggregated protein which in
turn leads to both an increase in sequestered aggregated
protein (SeqAggP) and binding of aggregated protein to
the proteasome (AggP_Proteasome). This is due to the
increase level of misfolded protein which can not be
degraded. On the other hand an increase in refolding (k3)
leads to a reduction in aggregation. Increased refolding
could occur if there was an upregulation in molecular
chaperones. Increasing the rate of binding of E3 to mis-
folded protein (k61) also reduces the level of aggregation
suggesting that, if a particular protein was involved in
aggregation, then overexpressing the relevant E3 for a mis-
folded protein could help to prevent the accumulation of
aggregates. However, aggregates are usually composed of
a variety of proteins, so this approach may not be feasible.
As expected, increasing the rate of aggregation by either
increasing k71 or k72 leads to more aggregation, and vary-
ing the parameters k73 or k74 changes the ratio of SeqAggP
to AggP_Proteasome.
Parameters which affect protein turnover
By setting the rate of protein synthesis, k1 to zero, we can
see which parameters affect the protein half-life. Figure 4
shows that with the default parameters, the protein half-
life in this model is about 10 hours. We both increased
and decreased each of the model parameters in turn by an
order of magnitude. We found that only three parameters
have an effect on protein half-life: k2, k68 and k69. The
parameter for the protein misfolding reaction (k2) is most
sensitive with a ten-fold increase leading to a ten-fold
decrease in protein half-life, and a ten-fold decrease lead-
ing to a ten-fold increase in half-life (Fig 4 green lines).
The parameter for proteasome activity (k69) only has an
effect when decreased, with a ten-fold decrease leading to
a four-fold increase in protein half-life (Fig 4, red line).
The reason that increasing k69 has no effect is that we
chose parameters so that under normal conditions protea-
somes are working well below their maximum capacity. A
ten-fold increase in the rate of shortening the chains of
polyubiquitinated misfolded protein bound to the pro-
teasome (k68), leads to a slight increase (× 1.4) in protein
half-life (Fig 4, blue line). This is due to more bound con-
jugates being released instead of being degraded by the
proteasome.
Shutting down E1 activity
The ts20 cell line is a Chinese hamster ovary line in which
a temperature-sensitive mutation in E1 allows functional
inactivation of this enzyme at the nonpermissive temper-
ature [31]. Figure 5 shows the results of the wet-lab and in
silico experiments wherein E1 activity is eliminated, and
subsequent conjugation of ubiquitin precluded. When
ts20 cells are cultured at 34°C and then subject to a tem-
perature shift to 42°C, there is initially no decline in ubiq-
uitin conjugates (Figure 5a, 30 minutes). Then after 1 to 2
hours, the conjugates start to disappear and there is a cor-
responding increase in the monomeric pool of ubiquitin.
The model predicts that when E1 activity is stopped (at
time = 0.5 hours), ubiquitin conjugates continue to
increase for a further half hour and then they start to
decline, with levels becoming low after 2 hours (from ces-
sation of E1 activity) and disappearing completely after 3
hours as shown in Fig 5b. Lowering the rate of DUB activ-
ity ten-fold, slowed down the removal of ubiquitin conju-
gates, so that it took 2.5 hours, after cessation of E1
Model parameters that affect protein half-life Figure 4
Model parameters that affect protein half-life. Results 
are shown for a typical simulation, for a 12 hour period. Pro-
tein synthesis was blocked by setting k1 = 0 with all other 
parameters as in Tables 2 and 3 except where indicated. The 
curves show the decline in total protein with time. The half-
life is the time when the total protein level is equal to 250.BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Shutting down E1 activity in ts20 cells Figure 5
Shutting down E1 activity in ts20 cells. (a) Time course of conversion of conjugates into monomeric ubiquitin 
pool Western blot analysis of cell extracts from ts20 cells cultured either at 34°C or 42°C for the indicated time with an anti-
body recognizing ubiquitin. The analysis revealed a detectable conversion of ubiquitin conjugates into monomeric ubiquitin in 
cells cultured at 42°C for 2 hours. Maintaining the cells at 42°C for an additional 1 or 2 hours did not significantly enhance the 
conversion of conjugates into the monomeric pool. The addition of proteasome inhibitor in the culture medium of cells cul-
tured at 42°C blocked the conversion of poly-ubiquitinated conjugates and resulted in their enhanced detection. The mem-
brane was re-probed with an actin specific antibody which served as a loading control (boxed panel). (b) Model output E1 
activity was blocked at time = 0.5 hours by setting the parameter k62 = 0 at this time point (indicated by dashed vertical line on 
the graph). All other parameters as in Tables 2 and 3. The simulations were repeated 100 times and the curves show the mean 
values. Ub conjugates includes all ubiquitinated misfolded protein both free and bound to the proteasome; total bound Ub 
includes ubiquitin bound to E1 and E2 enzymes in addition to ubiquitinated misfolded proteins. (c) As (b) except ten-fold lower 
DUB activity on polyubiquitinated proteasome-bound substrates (k68 = 1.0 × 10-6)BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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activity for the conjugates levels to reach low levels and
3.5 hours to completely disappear (Fig 5c)
Discussion
We have built a computer model of the ubiquitin-protea-
some system using an iterative process of model-building
and validation of the model against experimental data.
The initial conditions and parameters for the model were
chosen so that the model output fitted the experimental
data under normal conditions. The model was then vali-
dated by mimicking the experimental conditions such as
proteasome inhibition and shutting down E1 activity. For
example, with our original choice of parameters our
model predicted that if E1 activity is shut down, then there
is an almost immediate conversion of ubiquitin conju-
gates to monomeric ubiquitin. However, experimental
data show that this conversion takes about two hours (Fig
5a). Therefore, we adjusted the parameters to reduce the
rates of the reactions involved in ubiquitination, de-ubiq-
uitination and degradation until the model output fitted
the experimental data.
With this final set of parameters, the model output also
agrees with experimental data under normal conditions
and when the proteasome is inhibited. However, under
conditions of proteasome inhibition our model only
agrees with data for IMR-90 cells and not ts20 cells with
respect to the pool of monomeric ubiquitin. IMR-90 cells
are diploid fibroblast-like cells isolated from human fetal
lung [32]; they are nontransformed and with prolonged
culture will reach the Hayflick limit and undergo senes-
cence. The ts20 cell line is an immortalized line derived
from the E36 Chinese hamster ovary line [31]. Whereas
cell lines were found to be variable with respect to ubiqui-
tin content (Fig 3b) there did not seem to be a correlation
between ubiquitin content and immortalization or onco-
genic transformation (comparing the normal diploid
IMR-90 to the human glioblastoma line U87MG, for
example). It may be that the robust growth of transformed
cells places demands on ubiquitin pools and that such
cells have devised mechanisms to maintain or replenish
their pools; if so the IMR-90 results may be a more accu-
rate representation of normal ubiquitin homeostasis. In
order to be able to use our model for different cell types
(including transformed cells) it will be necessary to add
detail of ubiquitin turnover instead of assuming a con-
stant pool.
We carried out a sensitivity analysis to see which parame-
ters affect the model output, not only under normal con-
ditions but also under experimental conditions such as
proteasome inhibition and shutting down E1 activity.
Under normal conditions, pools of native protein were
affected by changing the protein synthesis or misfolding
rate, and pools of monomeric ubiquitin were affected by
changing the rate of polyubiquitinated misfolded binding
to the proteasome, the rate of chain shortening of polyu-
biquitinated misfolded protein bound to proteasomes, or
the rate of proteasome activity. Under conditions of pro-
teasome inhibition, increasing the rate of either protein
synthesis or protein misfolding, or decreasing the rate of
either refolding or binding of misfolded proteins to E3 led
to an increase in protein aggregation (and vice versa).
These results suggest that the availability of chaperones
and E3 enzymes are important in maintaining protein
homeostasis.
We also examined which parameters affect protein half-
life. The most important parameter in this respect was the
parameter for misfolding with a ten-fold increase/
decrease leading to a ten-fold decrease/increase in protein
half-life. Since the misfolding reaction can be driven by
the level of ROS in the cell, our model would predict a
similar outcome by changing ROS levels, with an increase
in ROS leading to higher misfolding and an increase in
degradation, consistent with current thought linking pro-
tein oxidation and ageing [33]. Our model predicts that a
ten-fold decrease in the rate of proteasome activity leads
to a four-fold increase in protein half-life but that an
increase in proteasome activity did not decrease protein
half-life. It has been suggested that since proteasome lev-
els can only increase slowly due to their slow assembly
time, that they must have residual capacity for degrading
proteins when cells are stressed [34]. Our model allows
for this residual capacity and explains why a ten-fold
increase in proteasome activity has no effect on protein
half-life.
There are also many other modifications that we could
make to the model. For example, we have assumed that E3
binds to misfolded protein in one simple step; however it
is likely that when a native protein misfolds, the first step
would be for a molecular chaperone (e.g. Hsp90) to bind
to the exposed hydrophobic surface to prevent inappro-
priate interactions. We could easily add this detail by
including the following steps:
MisP + Hsp90 ↔ Hsp90_MisP (reversible reaction)
Hsp90_MisP + E3 → E3_MisP + Hsp90
Similarly, we could include the possibility that chaper-
ones aid in delivery of ubiquitinated proteins to the pro-
teasome.
Our model includes a HECT E3, but it would be easy to
adapt the model for other types of E3 enzymes. For exam-
ple if E3 is a RING ligase, then it has to be in complex with
E2 before it can bind to the misfolded protein. This could
be represented by the following reactions:BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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E3 + E2_Ub ↔ E2_E3_Ub (reversible reaction)
MisP + E2_E3_Ub → E2_E3_MisP_Ub
E2_E3_MisP_Ub → MisP_Ub + E2 + E3
Our model only includes one pool of long-lived proteins
and so far ignores the fact that the majority of proteasome
activity is involved in the turnover of short-lived regula-
tory proteins and also the elimination of incorrect newly-
synthesised proteins. It would make the model more real-
istic to include an additional pool of short-lived proteins
and this work is currently in progress.
We have so far restricted our models of protein turnover
to the ubiquitin-proteasome system; however work is cur-
rently in progress to develop other models of protein turn-
over. It will be important to incorporate models of
lysosomal pathways since studies suggest that protein
aggregates such as mutant huntingtin are removed by
autophagy [reviewed in [35]].
We have included the possibility of aggregated protein
inhibiting proteasomes. Another possible cause of protea-
some inhibition is via unaggregated damaged protein
which could also sequester proteasomes. It would be
fairly straight forward to add this extra detail to our cur-
rent model. By running simulations over long time peri-
ods, the models can then be used to see how proteasome
activity is affected by damaged and/or aggregated protein.
This would be more realistic, than simply setting the
parameter for proteasome activity to zero.
Our model predicted that levels of native protein did not
change when misfolded protein levels rise, but in reality
we would not expect total protein levels to continually
rise. This prediction was due to our assumption of a con-
stant protein synthesis rate. We could later include detail
of feedback mechanisms such as the unfolded protein
response which downregulates translation when
unfolded protein accumulates in the endoplasmic reticu-
lum.
We have encoded our model using SBML which not only
allows for easy portability but also enables the model to
be modified and extended in a very straight-forward way.
The model is available on the BASIS website and can be
freely accessed from the public repository, so that the
interested reader can run simulations, make their own
modifications, or download the SBML code. The BASIS
website has a stochastic simulator and a database for stor-
ing models and simulation results.
Computer models of other molecular mechanisms
involved in ageing are being developed at Newcastle Uni-
versity, for example the role of mitochondria, the antioxi-
dant system, and DNA damage signalling pathways.
Methods to link models in an automated way are also
under development which will greatly facilitate the devel-
opment of integrated models. For example, our model of
the ubiquitin-proteasome system could be linked to a
model of the mitochondria. This would be very valuable
since neurodegeneration is not only associated with an
increase in aggregated protein but also an increase in dam-
aged mitochondrial DNA [36].
Conclusion
We have developed a model of the ubiquitin-proteasome
system using an iterative approach of model building and
validation against experimental data. We have used SBML
to encode the model to ensure that it can be easily modi-
fied and extended as more data become available. Impor-
tant aspects to be included in subsequent models are
details of ubiquitin turnover, models of autophagy, the
inclusion of a pool of short-lived proteins and further
details of the aggregation process. The model and its
extensions will be an invaluable aid to further our under-
standing of the cellular mechanisms involved in main-
taining protein homeostasis and how it is disturbed
during ageing.
Methods
Experimental Procedures
Cell culture
U87MG human glioblastoma cells, NIH-3T3 mouse
fibroblasts and IMR90 human fibroblasts were main-
tained in 5% CO2 at 37°C in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% of a 2:1 mix-
ture of fetal bovine and donor bovine serum. ts20 cells
harbouring a temperature sensitive E1 ubiquitin activat-
ing enzyme (a gift from Dr. Sergio Grinstein, University of
Toronto) were maintained in 5% CO2 at 34°C in DMEM
as above. Inactivation of E1 was achieved by incubating
the cells at 42°C for the indicated time. When proteasome
inhibitor (Calbiochem, San Diego, CA, USA) was used, it
was added to the culture medium 3 or 4 hours prior to
harvesting the cells for western analysis at a final concen-
tration of 50 μM.
Preparation of cell extracts for western blot analysis
Cells were harvested in protein lysis buffer (20 mM Tris-
HCl pH 7.5, 150 mM NaCl, 1% Nonidet P-40 (Sigma, St.
Louis, Missouri, USA), 0.5 mM EDTA, 5% glycerol) con-
taining the following protease and phosphates inhibitors:
phenylmethylsulfonyl fluoride, leupeptin (Sigma, St.
Louis, Missouri, USA), aprotinin (Sigma, St. Louis, Mis-
souri, USA), sodium fluoride (NaF), sodium pyrophos-
phate (NaPPi) and N-ethylmaleimide. The cell extracts
were sonicated and centrifuged at 14,000 rpm for 20 min-
utes at 4°C to pellet cellular debris. The soluble fractionsBMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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were recovered and the protein concentration was deter-
mined using the Bradford protein assay (Bio-Rad Labora-
tories Inc., Mississauga, Ontario, Canada). 40 μg of
cytoplasmic extracts were then resolved on a two-phase
SDS-polyacrylamide gel (15 and 8%) and electroblotted
onto a hybond C nitrocellulose membrane (Amersham
Pharmacia Biotech, Baie D'Urfé, Québec, Canada). The
membranes were autoclaved on a liquid cycle for 45 min-
utes to enhance the detection of poly-ubiquitinated pro-
teins, stained with Ponceau S (Sigma, St. Louis, Missouri,
USA) and analyzed by western blotting with the indicated
antibody. The proteins were visualized by a horseradish
peroxidase method using the ECL kit from Kirkegaard and
Perry Laboratories Inc., Gaithersburg, Maryland, USA.
Antibodies
The rabbit polyclonal antibody used to detect ubiquitin
was purchased from Dako. The mouse monoclonal anti-
bodies recognizing actin and GAPDH were from Sigma
(St. Louis, Missouri, USA) and Stressgen Bioreagents (Vic-
toria, British Columbia) respectively.
The Model
The model was built by first drawing a diagram of the sys-
tem (see Figure 1) and listing all the elements of the
model and the interactions between them. We then spec-
ified the initial amount of each element, the rate laws and
the values of the parameters. With this information, the
model can be translated into computer code and simu-
lated. To encode the model we used SBML shorthand [37]
which can then be converted into the Systems Biology
Markup Language (SBML), a computer-readable format
for representing biochemical models [38]. The model was
imported into the BASIS (Biology of Ageing e-Science
Integration and Simulation) system [39,40] and simula-
tions were carried out using a stochastic simulator based
on the Gillespie algorithm [41]. The SBML code is pro-
vided as supplementary material (see Additional file 1).
The model is also in the public repository of BASIS
(urn:basis.ncl:model:2215) and will soon be available
from the Biomodels database [42,43].
Elements of the model
It is first necessary to specify all the elements of the model
and the interactions between the elements. Using the ter-
minology of SBML, we refer to elements as "species" and
interactions as "reactions". The species needed for the
model are a pool of native proteins, misfolded proteins,
ubiquitin, ubiquitin activating enzyme (E1), ubiquitin
conjugating enzyme (E2), ubiquitin ligase (E3), de-ubiq-
uitinating enzymes (DUB), proteasomes, ATP, ADP, AMP,
reactive oxygen species (ROS), and complexes to represent
binding of elements e.g. ubiquitinated protein. A full list
of the species with their names, database terms and their
initial amounts is shown in Table 1.
Interactions between elements of the model
In our previous model of the chaperone system [30], we
included a single step for the degradation of misfolded
proteins:
where MisP represents the pool of misfolded protein.
We now replace this single step with a more detailed rep-
resentation of the ubiquitin-proteasome system.
Binding of E3 to misfolded protein
The first step in the degradation pathway is that the sub-
strate (in this case MisP) is bound to its specific ubiquitin
ligase (E3). The binding of E3 to MisP produces a complex
E3_MisP. This reaction is reversible and so we have two
reactions as follows:
We use mass action stochastic kinetics for the rate laws
[37]. The binding reaction is a second-order reaction since
there are two reactants and is given by k61<#E3><#MisP>,
where # denotes the number of molecules. The disassoci-
ation reaction is a first-order reaction and is given by
k61r<#E3_MisP>. The values for k61 and k61r can be esti-
mated from knowledge of the protein half-life and the
steady state level of protein in its misfolded state.
Action of ubiquitin enzymes, E1 and E2 leading to first 
ubiquitination event
Before a substrate can be ubiquitinated, ubiquitin must be
activated by the ubiquitin-activating enzyme (E1). This
reaction requires one molecule of ATP. The binding of E1
to ubiquitin (Ub) produces a complex which we denote
by E1_Ub:
The activated ubiquitin is then transferred to the ubiqui-
tin-conjugating enzyme (E2) which releases E1 making it
available for further ubiquitin-activating reactions:
Although it is possible that this reaction is reversible, it
seems unlikely that E2 would return the Ub to E1. So we
assume that the reverse reaction is negligible and do not
include it in the model. Ubiquitin bound to E2 is then
transferred to the misfolded protein bound to E3, releas-
ing E2 and E3:
MisP ATP ADP +⎯ → ⎯
k6
E3 MisP E3_MisP
E3_MisP E3 MisP
+⎯ → ⎯⎯
⎯→ ⎯⎯ +
k
k r
61
61
E1 Ub ATP E1_Ub AMP ++ ⎯ → ⎯⎯ +
k62
E2 E1_Ub E2_Ub E1 +⎯ → ⎯⎯ +
k63BMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Extending the ubiquitin chain
Further ubiquitin is then attached to the monoubiquiti-
nated protein via the action of E2. Since each ubiquitin
molecule must be activated by E1 before being transferred
to E2, each step in the formation of polyubiquitin chain
uses one molecule of ATP. The extension of the ubiquitin
chain is modelled by the following set of reactions:
Each of the above reactions is reversible, with the reversi-
ble reactions requiring the activity of a deubiquitinating
enzyme (DUB). We assume that the shortening of ubiqui-
tin chains by DUBs is a step-wise process, although we
could later modify the model to allow whole chains to be
removed if it becomes of interest to model this. The step-
wise removal of ubiquitin is modelled by the following
reactions:
Binding to the proteasome and degradation
We assume that ubiquitinated protein first binds to the
proteasome and waits for degradation and that it can
remain bound so long as at least 4 ubiquitin sub-units are
attached. This can be modelled by the following reactions:
where MisP_Ub4_Proteasome etc. represents an ubiquiti-
nated protein bound to the proteasome.
Bound ubiquitinated protein can also be de-ubiquitinated
in a step-wise process, so that proteins with longer chains
stay longer at the proteasome. This is modelled by the fol-
lowing set of reactions:
When a bound protein has a chain shorter than four, then
it dissociates from the proteasome. This is shown in the
following reaction:
Any protein which has a chain of four or more ubiquitin
molecules may be degraded by the proteasome in an ATP
dependent reaction:
Protein synthesis and refolding
This model can either be combined with the chaperone
model [30] or can be explored as a separate module. In
order to investigate how the various parameters and spe-
cies amounts affect the model predictions for the rate of
protein turnover, we first carried out simulations on the
separate module. In order to do this we added the reac-
tions of protein synthesis, protein misfolding and protein
refolding to the model:
The rate of misfolding depends on the level of reactive
oxygen species (ROS) within the cell. We have omitted
details of the chaperone activity, where a misfolded pro-
tein would bind to Hsp90 before refolding can take place.
However, when we combine the models, this simple reac-
tion will be replaced with the more detailed reactions
given in Proctor et al., [30]. In this model, we assume that
ROS takes a constant value throughout the simulation but
we can look at the effect of varying the amount of ROS. It
would also be simple to add reactions for the generation
and removal of ROS which would then make it possible
to examine the effects of increasing ROS over time.
Protein aggregation
If a misfolded protein is not removed immediately by
refolding or degradation, then there is a chance that it will
interact with another misfolded protein to form a small
aggregate, or it may interact with an existing aggregate to
form a larger aggregate. (Here we will not be concerned
with the size of aggregates – a more detailed model is in
preparation). An aggregate may be sequestered to prevent
it interfering with the cellular machinery or it may bind to
the proteasome. We include enough detail to be able to
examine whether an increase in misfolding (for example
by an increase in levels of ROS) leads to an increase in
aggregation and inhibition of the proteasome which in
turn leads to an even greater level of aggregated protein.
The following set of reactions show how protein aggrega-
tion can be simply modelled:
where AggP represents the pool of aggregates. The aggre-
gates may be sequestered (SeqAggP) which keeps them
E2_Ub E3_MisP MisP_Ub E2 E3 +⎯ → ⎯⎯ + +
k64
MisP_Ub E2_Ub MisP_Ub2 E2
MisP_Ub(i) E2_Ub MisP
+⎯ → ⎯⎯ +
+⎯ → ⎯⎯
k
k
65
65 _ _Ub(i 1) E2 (i 2,...7) ++ =
MisP_Ub(i) DUB MisP_Ub(i-1) DUB (i 8,...2) +⎯ → ⎯⎯ + =
k66
MisP_Ub(i) Proteasome MisP_Ub(i)_Proteasome (i 4,..., +⎯ → ⎯⎯ =
k67 8 8)
MisP_Ub(i)_Proteasome DUB MisP_Ub(i-1)_Proteasome Ub +⎯ → ⎯⎯ +
k68 + += DUB (i 8,...,5)
MisP_Ub4_Proteasome DUB MisP_Ub3 Proteasome DUB +⎯ → ⎯⎯ + +
k68
MisP_Ub(i)_Proteasome ATP iUb Proteasome ADP (i 4,... +⎯ → ⎯⎯ + + =
k69 , ,8)
k
k
k
1
2
3
⎯→ ⎯
+⎯ → ⎯+
⎯→ ⎯
NatP,
NatP ROS MisP ROS,
MisP NatP.
2MisP AggP
MisP AggP 2AggP
AggP SeqAggP
Agg
k
k
k
71
71
73
⎯→ ⎯⎯
+⎯ → ⎯⎯
⎯→ ⎯⎯
P P Proteasome AggP_Proteasome +⎯ → ⎯⎯
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out of harms way, or they may bind to the proteasome
(AggP_Proteasome) and so inhibit its function. Ubiquiti-
nated misfolded protein may also form aggregates but this
will not normally occur unless the proteasome is inhib-
ited. As there are many ways in which misfolded proteins
with ubiquitin chains of different lengths can interact, we
only list a subset of the reactions:
Setting the initial amounts of the species and parameter 
values
Before the model can be simulated, it is necessary to spec-
ify the initial amounts of each species and the parameter
values. There is experimental data on levels of ubiquitin
and proteasomes in human cells. For example, Haas et al.
[44] measured levels of monomeric ubiquitin and conju-
gated ubiquitin in IMR-90 cells giving values of 71.5
pmol/106 cells and 61.1 pmol/106 cells respectively. From
this we can calculate that there are approximately 107
ubiquitin molecules per cell (estimated at between 1 and
10% of total protein molecules). Since we are only mod-
elling part of the total cellular protein, we have scaled
down the level of ubiquitin to 500 molecules per cell. The
total level of proteasomes per cell has been estimated to
be 8 × 105 per cell in L929 cells [34] which gives a ratio of
about one proteasome to every 10 ubiquitin molecules.
Since ubiquitin has many other functions apart from the
ubiquitin-proteasome pathway, the ratio of proteasomes
to ubiquitin must be less than 1:10 and so we assumed a
ratio of 1:5.
The level of E1 has been measured in IMR90 cells by west-
ern analysis of cell lysate compared to recombinant pro-
tein (Tsirigotis and Gray, unpublished data) and is
estimated to be 1 million molecules per cell. This is one
order less than the level of ubiquitin and so we chose an
initial amount of 100 for E1. We do not have data for E2
or E3 enzymes but for the sake of building the model
assume that for specific substrates these would be present
at roughly the same abundance as E1. We do not have any
experimental data for the abundance of DUBs within cells
but assume that these are less abundant than ubiquitin
and set the initial amount to 200.
The level of native protein, NatP, was set at 500 and at this
level the ratio of native protein to ubiquitin and proteas-
omes enabled efficient degradation to take place. If we
increased the level of NatP to 5000, then it was also nec-
essary to increase the pool of ubiquitin and proteasomes
to prevent depletion of monomeric ubiquitin under nor-
mal conditions. The levels of ATP, ADP and AMP were set
at a fairly arbitrary level of 10000, 1000 and 1000 respec-
tively and the levels were kept constant by imposing a
boundary condition to these species. We chose to do this
instead of allowing the levels to fluctuate as cells possess
mechanisms to maintain ATP levels at fairly constant lev-
els and it is unlikely that the ubiquitin-proteasome system
would cause major changes to levels of these molecules.
ROS levels were set at an arbitrary value of 10 and the level
remained constant as there are no mechanisms in this
model that would cause ROS levels to change. The initial
amounts of all the species are shown in Table 1.
The default values for the model parameters are shown in
Tables 2 and 3. Where possible values were chosen to
2MisP_Ub AggP
MisP_Ub AggP 2AggP
MisP_Ub8 AggP
k
k
k
72
72
⎯→ ⎯⎯
+⎯ → ⎯⎯
+
#
7 72
72
72
⎯→ ⎯⎯
+⎯ → ⎯⎯
+⎯ → ⎯⎯
2AggP
MisP MisP_Ub AggP
MisP MisP_Ub8 Ag
k
k
#
g gP
MisP_Ub7 MisP_Ub8 AggP 
#
+⎯ → ⎯⎯
k72
Table 3: List of reactions and parameter values for the aggregation process
Reaction Kinetic rate law Reactants Products Parameter
name
Valuea
Aggregation1 k71<#MisP><#MisP-1>/2.0 2MisP AggP k71 1.0E-8 mol-1 s-1
Aggregation2 k71<#MisP><#AggP> MisP, AggP 2AggP k71 1.0E-8 mol-1 s-1
Aggregation3 k72<#MisP_Ub><#MisP_Ub-1>/2.0 2MisP_Ub AggP k72 1.0E-8 mol-1 s-1
    
Aggregation10 k72<#MisP_Ub8><#MisP_Ub8-1>/2.0 2MisP_Ub8 AggP k72 1.0E-8 mol-1 s-1
Aggregation11 k72<#MisP><#MisP_Ub> MisP, MisP_Ub AggP k72 1.0E-8 mol-1 s-1
    
Aggregation54 k72<#MisP_Ub7><#MisP_Ub8> MisP_Ub7, MisP_Ub8 AggP k72 1.0E-8 mol-1 s-1
SequesteringOfAggregates k73<#AggP> AggP SeqAggP k73 1.0E-3 s-1
ProteasomeInhibition k74<#AggP> AggP, Proteasome AggP_Proteasome k74 1.0E-5 s-1
amol, number of moleculesBMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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reflect experimental measurements. For example, the
parameters for protein synthesis and misfolding can be
calculated from knowledge of the protein half-life and the
steady state levels of misfolded protein. Other parameter
values such as those for the ubiquitin pathway are cur-
rently unknown but experimental work in the lab of DG
is being carried out to quantify some of the reactions rates.
Before this data becomes available, we try to find a set of
parameters that will give output corresponding to the
expected steady state of an unstressed cell e.g. no accumu-
lation of misfolded protein and only small fluctuations in
levels of native protein, ATP, ADP and ROS. To do this we
initially estimate the unknown parameters and then run a
simulation and check the model output. The parameters
shown in Tables 2 and 3 corresponded to a steady state as
shown in Figure 2b. We then investigated which parame-
ters affected the half-life of the protein substrate by setting
the rate of protein synthesis to zero and altering each of
the other parameters in turn. We also examined the effects
of inhibiting the proteasome by setting the parameter for
degradation to zero and the effects of shutting down E1
activity. For example, with our original choice of parame-
ters our model predicted that if E1 activity is shut down,
then there is an almost immediate conversion of ubiqui-
tin conjugates to monomeric ubiquitin. However, experi-
mental data shows that this conversion takes about two
hours (Fig 5a). Therefore, we adjusted the parameters to
reduce the rates of the reactions involved in ubiquitina-
tion, de-ubiquitination and degradation until the model
output fitted the experimental data.
We now describe each of the parameters in turn and give
an interpretation of their values in terms of reaction kinet-
ics. The parameters k1, k2 and k3 were set so that the half-
life of the pool of protein equals about 10 hours, and
under normal conditions, there is only a very low propor-
tion of misfolded protein [45]. The parameter k61 for E3/
MisP binding is set so that the average time for one E3 to
bind to MisP is about 10 minutes. The parameter k61r is set
so that the reverse reaction (dissociation of E3 from MisP)
happens once every 100 minutes. So the forward reaction
is 10 times stronger than the reverse reaction. The param-
eter k62 for E1/Ub binding is set so that about 40 ubiquitin
molecules are activated every minute and the parameter
k63 for E2/Ub binding is set to give about 6 reactions per
minute. The parameter k64 for monoubiquitination is set
so that once MisP is bound by E3 it takes about 10 sec-
onds to receive the first Ub molecule. The parameter k65
for polyubiquitination is set so that it took about one sec-
ond for each additional Ub molecule to be added to the
chain. So each polyubiquitination step is about 10 times
faster than the first ubiquitination reaction. The parame-
ter k66 for the de-ubiquitination reactions is set so that it
takes about 8 minutes for each reaction. It is necessary that
this reaction is very slow compared to the ubiquitination
reactions so that the model output fits the experimental
data when E1 activity is shut down (see section 4.4). The
parameter k67 for the binding of ubiquitinated proteins
(with chains of 4 or more ubiquitin molecules) to the pro-
teasome is set so that under normal conditions when
there are about 200 ubiquitin conjugates present in the
cell, on average about 5 reactions per second are occur-
ring. The parameter k68 for the de-ubiquitination of pro-
teasome-bound ubiquitinated proteins is set to be equal
to k66. We assume that this reaction is slow so that pro-
teins with long chains are highly likely to reside long
enough at the proteasome for degradation to take place,
whereas proteins with short chains may be shortened to
below the required threshold and would then dissociate
from the proteasome. The parameter k69 for proteasome
activity is set so that it takes about 15 seconds to degrade
each proteasome-bound ubiquitinated protein. We ini-
tially set k71 and k72 to be equal to 10-7 as in the model of
Proctor et al. [30]. However, with these values, aggregates
sometimes formed even under normal conditions (data
not shown). Therefore we lowered the values until we
obtained results in which the appearance of aggregates
was very unlikely under normal conditions. This was sat-
isfied with k71 and k72 set equal to 10-8, The parameter k73
for sequestering aggregates is set so that if there is a low
level of aggregates in the cell (1–10), then on average
there are 0.005 reactions per second, so each reaction
takes about 3 minutes for each reaction.
The parameter k74 is set so that there is an equal probabil-
ity of an aggregated protein being sequestered or binding
to the proteasome when all the proteasomes are available
for binding.
Adapting the model to mimic different experimental 
procedures
Proteasome inhibition
We carried out an in silico experiment of inhibiting the
proteasome by setting the parameter k69 = 0. We also var-
ied each of the other parameters in turn to see which
parameters affect the aggregation kinetics.
Table 4: Event structure for shutting down E1 activity in the computer model
event trigger event assignment reactions affected
Increase temperature t >= 1800 k62 = 0 E1/Ub bindingBMC Systems Biology 2007, 1:17 http://www.biomedcentral.com/1752-0509/1/17
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Blocking protein synthesis
By setting the parameter for protein synthesis, k1, to zero
we can use our model to check the half-life of the protein
pool. We also varied each of the other parameters in turn
to see which parameters affect the half-life. For each
parameter we increased and decreased its value ten-fold,
re-ran the simulations and plotted the model output.
Shutting down E1 activity
It is very straight forward to mimic this experiment with
our in silico model by adding an event to the SBML code
so that at a certain time-point the parameter for the E1/Ub
binding reaction is set to zero. This event is equivalent to
putting the cells at the non-permissive temperature in the
wet lab experiment. We chose 30 minutes as the time-
point at which this event occurred to allow time for ubiq-
uitin conjugates to form. The details of the event are given
in Table 4.
Statistical analysis of repeat runs
Statistical analysis of repeated simulations was carried
using the R programming language.
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